Tag: androgen deprivation therapy

Aggressive prostate cancer (PCa) comes with higher chances for recurrence—and often there’s no way to know if the PCa has started to spread at the time of treatment. It’s like a time bomb with an unanswered question: has the clock been activated? Therefore, today’s clinical standard of care treats it as if the clock is keep reading

What does prostate cancer have in common with chameleons that can change their skin color? These lizards have a remarkable ability to alter their appearance in response to environmental pressure — that is, changes in their circumstances that threaten their survival. They need to eat, so they can either blend in with muted background colors keep reading

I was fascinated by a revealing new research study concerning prostate cancer (PCa) and the gut microbiome. Even though the prostate gland and the intestines are both located in the abdominal cavity, nature has ensured that they are separated so dangerous E. coli bacteria in the bowel can’t contaminate the urinary/sexual system. However, there may keep reading

When it comes to men and women, the French declare “Vive la difference!” Long live the difference, which is heavily based in our body’s biochemistry, especially hormones. The primary androgen (male hormone) that makes men MEN is testosterone, and healthy masculinity is certainly worth celebrating. However, when it comes to prostate cancer (PCa), there’s a keep reading

Not long ago, I posted a blog on the ability of androgen deprivation therapy (ADT) to boost the effectiveness of radiation therapy for prostate cancer. This synergistic effect is very important for men with intermediate or higher risk cancer who can’t have (or don’t want) radical prostatectomy, since the greater the risk, the more likely keep reading